Taken together, this suggests that the transcriptional upregulation in HCC tumors observed for CASP2 and PIDD1 is directly linked to the higher proliferation rates in the tumor while the expression of RAIDD is uncoupled from the proliferative state. The gene discussed is CASP2; the disease is hepatocellular carcinoma.